We have located links that may give you full text access.
An MRI-based radiomics nomogram for differentiating spinal metastases from multiple myeloma.
BACKGROUND: Spinal metastasis and multiple myeloma share many overlapping conventional radiographic imaging characteristics, thus, their differentiation may be challenging. The purpose of this study was to develop and validate an MRI-based radiomics nomogram for the differentiation of spinal metastasis and multiple myeloma.
MATERIALS AND METHODS: A total of 312 patients (training set: n = 146, validation set: n = 65, our center; external test set: n = 101, two other centers) with spinal metastasis (n = 196) and multiple myeloma (n = 116) were retrospectively enrolled. Demographics and MRI findings were assessed to build a clinical factor model. Radiomics features were extracted from MRI images. A radiomics model was constructed by the least absolute shrinkage and selection operator method. A radiomics nomogram combining the radiomics signature and independent clinical factors was constructed. And, one experienced radiologist reviewed the MRI images for all case. The diagnostic performance of the different models was evaluated by receiver operating characteristic curves.
RESULTS: A clinical factors model was built based on heterogeneous appearance and shape. Twenty-one features were used to build the radiomics signature. The area under the curve (AUC) values of the radiomics nomogram (0.853 and 0.762, respectively) were significantly higher than that of the clinical factor model (0.692 and 0.540, respectively) in both validation (p = 0.048) and external test (p < 0.001) sets. The AUC values of the radiomics nomogram model were higher than that of radiologist in training, validation and external test sets (all p < 0.05). Moreover, no significant difference in AUC values of radiomics nomogram model was found between the validation set and external test set (p = 0.212).
CONCLUSION: The radiomics nomogram can differentiate spinal metastasis and multiple myeloma with a moderate to good performance, and may be as a valuable method to assist in the clinical diagnosis and preoperative decision-making.
MATERIALS AND METHODS: A total of 312 patients (training set: n = 146, validation set: n = 65, our center; external test set: n = 101, two other centers) with spinal metastasis (n = 196) and multiple myeloma (n = 116) were retrospectively enrolled. Demographics and MRI findings were assessed to build a clinical factor model. Radiomics features were extracted from MRI images. A radiomics model was constructed by the least absolute shrinkage and selection operator method. A radiomics nomogram combining the radiomics signature and independent clinical factors was constructed. And, one experienced radiologist reviewed the MRI images for all case. The diagnostic performance of the different models was evaluated by receiver operating characteristic curves.
RESULTS: A clinical factors model was built based on heterogeneous appearance and shape. Twenty-one features were used to build the radiomics signature. The area under the curve (AUC) values of the radiomics nomogram (0.853 and 0.762, respectively) were significantly higher than that of the clinical factor model (0.692 and 0.540, respectively) in both validation (p = 0.048) and external test (p < 0.001) sets. The AUC values of the radiomics nomogram model were higher than that of radiologist in training, validation and external test sets (all p < 0.05). Moreover, no significant difference in AUC values of radiomics nomogram model was found between the validation set and external test set (p = 0.212).
CONCLUSION: The radiomics nomogram can differentiate spinal metastasis and multiple myeloma with a moderate to good performance, and may be as a valuable method to assist in the clinical diagnosis and preoperative decision-making.
Full text links
Related Resources
Trending Papers
Molecular Therapeutics for Diabetic Kidney Disease: An Update.International Journal of Molecular Sciences 2024 September 19
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app